Syngene International Faces Decline Amid Broader Market Trends and Mixed Performance Indicators

Syngene International, a key player in the pharmaceuticals and drugs sector, has experienced a notable decline of 3.68% on January 13, 2025. This drop is part of a broader trend, as the stock has underperformed relative to its sector peers, falling 2.43% in comparison. Over the last two days, Syngene has seen a cumulative decrease of 5.02%.
On this trading day, the stock reached an intraday low of Rs 832, marking a decrease of 3.33%. Analyzing its moving averages, Syngene's stock is currently positioned above its 200-day moving average but below the 5-day, 20-day, 50-day, and 100-day moving averages, suggesting mixed short-term performance.

In the context of the broader market, Syngene's one-day performance contrasts with the Sensex, which declined by only 0.47%. Over the past month, Syngene's stock has decreased by 4.38%, while the Sensex has experienced a slightly larger drop of 6.23%.